Today: 8 June 2026
T-Mobile stock is up today: TMUS holds steady as Fed minutes loom in thin year-end trade
30 December 2025
1 min read

T-Mobile stock is up today: TMUS holds steady as Fed minutes loom in thin year-end trade

NEW YORK, December 30, 2025, 12:45 ET — Regular session

  • T-Mobile shares edged higher in midday trading as U.S. stocks churned in holiday-thin conditions.
  • Investors’ focus was on Federal Reserve meeting minutes due later Tuesday.
  • Verizon and AT&T also traded slightly higher, keeping the big U.S. wireless group in step.

Shares of T-Mobile US, Inc. (TMUS) were up about 0.2% at $203.55 in midday trade on Tuesday. The stock has traded between $202.00 and $203.71 so far in the session.

The modest move came as U.S. stocks hovered near flat in a holiday-truncated week, with communication services among the day’s stronger pockets and investors awaiting minutes from the Federal Reserve’s Dec. 9-10 meeting later in the day. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide, referring to recent shifts in positioning after a tech-led run. Reuters

T-Mobile’s gains tracked its big U.S. wireless peers, with Verizon up about 0.4% and AT&T up roughly 0.2%.

The stock is coming off a 1.1% rise on Monday to close at $203.15, its fourth straight session of gains, even as the broader market slid.

Why this matters now is less about company-specific headlines and more about where money is moving at year-end, when lower liquidity can amplify sector rotations. Telecom stocks tend to sit at the intersection of defensive positioning and rate expectations.

Fed minutes are a detailed account of policymakers’ debate. They can shift expectations for the path of interest rates, which can ripple through equity sectors that trade on valuation and cash-flow stability.

Investors will be watching whether the minutes reinforce the Fed’s cautious tone after its last quarter-point cut (0.25 percentage point). Any change in language around inflation and the pace of future moves can sway risk appetite into early 2026.

The next major company catalyst is T-Mobile’s fourth-quarter and full-year 2025 earnings update and capital markets day refresh, scheduled for Feb. 11, 2026, the company said.

Traders will be listening for updates on postpaid subscriber trends (customers who pay after using the service), broadband additions and free cash flow, as well as any changes to capital-return plans.

For now, TMUS is trading in a tight range, and the market’s near-term tone is likely to be set by the Fed minutes and year-end positioning rather than single-stock news.

Stock Market Today

  • Steve Eisman Expresses Skepticism Over Upcoming SpaceX IPO
    June 8, 2026, 8:27 AM EDT. Steve Eisman, known for his role in the 2008 financial crisis detailed in 'The Big Short,' voiced his reservations about the upcoming SpaceX IPO on CNBC's 'Squawk Box.' Eisman, a seasoned investor and former Neuberger Berman portfolio manager, said he is 'not a fan' of the public offering. He discussed broader market trends and expressed caution regarding valuation and growth prospects for the aerospace company. SpaceX's impending listing remains highly anticipated, but Eisman's comments highlight investor concerns over high-profile IPOs in the current market climate.

Latest articles

NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
SoFi Stock Trades Near $16 as Market Watches Monday’s Open

SoFi Stock Trades Near $16 as Market Watches Monday’s Open

8 June 2026
SoFi hovered near $16 in pre-market trading after a sharp drop last week, as investors weighed record Q1 growth against unchanged 2026 guidance and credit risks; shares sit far below their 52-week high, with CEO Noto citing persistent inflation and no expected rate cuts as reasons for not raising forecasts, leaving pressure on Monday’s regular session to halt the slide.
Marvell Heads Higher Ahead of S&P 500 Inclusion

Marvell Heads Higher Ahead of S&P 500 Inclusion

8 June 2026
Marvell Technology surged 7% premarket after S&P Dow Jones Indices said it will join the S&P 500 on June 22, triggering forced buying by index funds; shares traded at $282.50, up from $263.47, as investors responded to record AI-driven revenue, raised outlooks, and the prospect of broad portfolio inclusion.
FuelCell Energy Down 19% as AI Test Looms

FuelCell Energy Down 19% as AI Test Looms

8 June 2026
FuelCell Energy stock plunged 19.02% Friday to $17.33 ahead of Monday’s fiscal Q2 results, as investors await proof that AI data-center demand is translating into real orders and revenue; analysts expect a $0.52 per share loss on $40.5 million revenue, with focus on backlog, cash use, and whether recent gains—up 137% in 2026—are sustainable amid index inclusion and sector volatility.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop